Simplifying How You Access Healthcare
We’re happy to introduce our new, user-friendly platform, PfizerForAll.com, where the millions of Americans with illnesses like migraine, COVID-19 and flu can receive end-to-end services and support all in one place.
Articles
Clinical Trial Innovation: Putting the Patient First in Clinical Trial Design
Every day, across the United States and around the world, scientists are developing potential new medicines and vaccines that could change lives. But to get medicines and vaccines to the patients who need them most, they must first undergo a clinical trial, which is a research study that seeks to understand how potential medicines and other medical treatments work.These studies depend on the generosity of participants, who volunteer to be a part of the trial. Depending on the type of trial....
- Purpose & Ideals
From Internship to C-Suite, Pfizer Executive Pays It Forward
Image caption: Payal Sahni and her parents celebrate World Refugee Day 2023 at Pfizer’s New York HeadquartersWhen Payal Sahni Becher reflects on the valuable lessons that have shaped her life, the one that stands out most is the power of saying “yes.” For Sahni Becher, who is Pfizer’s Chief People Experience Officer, saying “yes” to an internship opportunity at Pfizer 27 years ago paved the path to her current leadership role.Many years before, when she was just 6 years old, her parents made the....
- Real People
An Accord for a Healthier World: Working Together to Help Address Unmet Healthcare Needs in Lower-Income Countries
Currently, regulatory agencies may take up to seven years to approve essential medicines and vaccines in low- and middle-income counties (LMICs) from the time those same treatments were first approved in high-income countries, if they are approved at all.1 The burden remains disproportionately higher in low-income countries.2 Lack of access to quality healthcare is related to healthcare inequities in LMICs and hinders equitable access to safe and effective treatments.2Those living in LMICs....
- Purpose & Ideals
In Celebrating 175 Years, Pfizer Challenges Itself to ‘Outdo Yesterday’
Image caption: Site of the Pfizer World Headquarters Building as it Appeared in 1861It started with a breakthrough.The year was 1849, and people everywhere were getting sick to their stomachs. In the days before widespread refrigeration, a simple meal of meat and potatoes could cause intestinal worms. A drug called santonin could kill the parasites, but it tasted so bitter many people avoided it.Charles Pfizer and his cousin, Charles Erhart, had just immigrated to the U.S. from Germany and....
- Science & Innovation
Pfizer's Multicultural Health Equity Collective Marks 10 Years of Progress
Marginalized communities in the United States have faced generations of health inequities due to systemic discrimination embedded into our healthcare system. Life expectancy in the U.S., for instance, masks significant racial and ethnic disparities – the average life expectancy for non-Hispanic American Indians or Alaska Natives is seven years lower than it is for non-Hispanic whites.1
- Programs & Initiatives
Advocacy, Strength, and Hope in the Face of Metastatic Melanoma: Bruce and Chris's Story
In 2013, Bruce’s life changed. He was living in sunny Florida with Chris, his wife of over 20 years, when he received an unexpected diagnosis: metastatic melanoma—the most aggressive form of skin cancer.1,2It was a disease Bruce had heard of before—a disease that will impact over 100,000 people in the U.S. this year and 510,000 people across the world by 2040.2,3 But it didn’t cross his mind when he noticed a small lesion on the top of his foot. Chris encouraged Bruce to get it checked out. In....
- Real People
Got Yours? Spokesperson Martha Stewart on Health and Wellness
Martha Stewart has seemingly done it all – she’s a lifestyle expert, media mogul, and even founded a care center to support the geriatric population.She recently chatted with Pfizer.com about why she joined the Got Yours? COVID-19 vaccination campaign, how her father’s job at Pfizer impacted her view on science, how she juggles her busy schedule and more!Pfizer: The first thing we wanted to ask you is why you chose to partner with Pfizer, and if you've had a favorite part of being involved in....
- Real People
Severe COVID-19 and the Continuing Importance of Protecting High Risk Populations
The concept of "severe COVID-19" can be a frightening one, especially when the term itself is so often misunderstood or confused with having self-assessed severe symptoms of COVID-19.Approximately 80% of those who test positive for COVID-19 have mild to moderate illness.1 But adults 50 and older and people of any age with certain underlying health conditions are at high risk of progression to severe COVID-19. That adds up to two in five people worldwide who are at increased risk for severe COVID....
- Living & Wellbeing
The Future of Pharmacovigilance: Monitoring Medicine and Vaccine Safety Using AI and Other Tech
While many Pfizer colleagues worked to, develop and manufacture a vaccine for COVID-19, one Pfizer team was hard at work monitoring the safety of the COVID-19 vaccine trial. And they did so while also maintaining safety monitoring operations for more than 1,000 other products in the Pfizer portfolio.Pharmacovigilance is the name for the area of science which scientists and medical professionals monitor medicine and vaccine-related safety issues. “Medicine and vaccine safety is one of those....
- Programs & Initiatives
Announcements
09.11.2024 Events Diversity & Inclusion Pfizer Culture Technology Pfizer Wraps Up 8th Year of Immersive Girls Who Code Program 09.03.2024 Updates & Statements Albert Bourla Cancer Health Equity Leadership Pfizer Culture August Social Media Round-Up—the Summer Games, Girls Who Code, and More 08.29.2024 Events Autoimmune Diseases Diseases & Conditions Living with Alopecia Areata 08.27.2024 Updates & Statements Covid-19 Health Equity Influenza Migraines Technology Vaccines PfizerForAll Strives to Simplify How You Access Healthcare
Behind the Science Features
Subscriptions
Sign up for communications from Pfizer
Receive the latest news from Pfizer in our monthly The Breakthrough newsletter and email alerts on a variety of topics.
Newsroom
The latest media resources from Pfizer
Working journalist? Visit the Pfizer Newsroom for our complete library of news, announcements and multimedia assets.